Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Farmers Insurance
Federal Trade Commission
Boehringer Ingelheim
Argus Health
Harvard Business School

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 207917

« Back to Dashboard

NDA 207917 describes EPIDUO FORTE, which is a drug marketed by Galderma Labs and is included in one NDA. It is available from one supplier. There are eight patents protecting this drug and one Paragraph IV challenge. Additional details are available on the EPIDUO FORTE profile page.

The generic ingredient in EPIDUO FORTE is adapalene; benzoyl peroxide. There are eleven drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the adapalene; benzoyl peroxide profile page.

Summary for 207917

Formulation / Manufacturing:see details

Pharmacology for NDA: 207917


Suppliers and Packaging for NDA: 207917

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917 NDA Galderma Laboratories, L.P. 0299-5906 0299-5906-05 1 TUBE in 1 BLISTER PACK (0299-5906-05) > 5 g in 1 TUBE
EPIDUO FORTE adapalene; benzoyl peroxide GEL;TOPICAL 207917 NDA Galderma Laboratories, L.P. 0299-5906 0299-5906-60 1 BOTTLE, PUMP in 1 CARTON (0299-5906-60) > 60 g in 1 BOTTLE, PUMP

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GEL;TOPICALStrength0.3%;2.5%
Approval Date:Jul 15, 2015TE:RLD:Yes
Regulatory Exclusivity Expiration:Jul 15, 2018
Regulatory Exclusivity Use:NEW PRODUCT
Patent:► SubscribePatent Expiration:Dec 23, 2022Product Flag?Substance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Mar 12, 2023Product Flag?Substance Flag?Delist Request?

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch: